| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/22/2002 | CN1349820A Application of shinyleaf yellowhorn fruit shell in preparing cerbral function improving food and medicine |
| 05/22/2002 | CN1349809A Chinese herbal medicine for treating various fish diseases |
| 05/22/2002 | CN1085208C Process for preparing eprosartan |
| 05/22/2002 | CN1085205C Bicyclic amino acids |
| 05/22/2002 | CN1085094C Body-building medicated pillow |
| 05/21/2002 | US6392100 Antiinflammatory agents; antiproliferative agents; immunosuppressants; viricides |
| 05/21/2002 | US6392045 9-azobicyclo[3.3.1] non-2-ene derivatives as cholinergic ligands at nicotinic ACH receptors |
| 05/21/2002 | US6392039 Coupling; salt formation |
| 05/21/2002 | US6391922 Administering neurotransmitter |
| 05/21/2002 | US6391914 Optically active aminopentane derivatives |
| 05/21/2002 | US6391910 Opioid antagonist; analgesic |
| 05/21/2002 | US6391909 Anandamide inhibitors as analgesic agents |
| 05/21/2002 | US6391908 Oxime amide indole type sPLA2 inhibitors |
| 05/21/2002 | US6391907 Anticancer agents; contraceptives |
| 05/21/2002 | US6391899 Stroke therapy; cardiovascular disorders |
| 05/21/2002 | US6391894 Myt1 kinase inhibitors |
| 05/21/2002 | US6391892 Naphthyl pharmaceutical compounds |
| 05/21/2002 | US6391891 Bicyclic compounds as ligands for 5-HT1 receptors |
| 05/21/2002 | US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors |
| 05/21/2002 | US6391872 Indazole bioisostere replacement of catechol in therapeutically active compounds |
| 05/21/2002 | US6391866 Analgesics |
| 05/21/2002 | US6391856 Method for treatment of allergic reaction using formyl peptide |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391852 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/21/2002 | US6391848 Soybean protein nutraceuticals |
| 05/21/2002 | US6391616 Oidiodendron strain for the production of terpenoid lactone compounds |
| 05/21/2002 | US6391588 Nucleotides squences coding preferential amino acid sequences for use in treating bone disorder in mammals |
| 05/21/2002 | US6391580 Ras proteins |
| 05/21/2002 | US6391344 By administering rosemary or sage extracts; carnosic acid, carnosol |
| 05/21/2002 | US6390821 Phosphorylation |
| 05/21/2002 | CA2268327C 3-carboxamide derivatives of 5h-pyrrolo[2,1-c][1,4]-benzodiazepines |
| 05/21/2002 | CA2223245C Catechol diethers derivatives useful as pharmaceutical agents |
| 05/21/2002 | CA2216664C New n-substituted cyclical amines, their preparation process and the pharmaceutical compositions containing them |
| 05/21/2002 | CA2183241C Yeast strains and modified albumins |
| 05/21/2002 | CA2134077C 4-imidomethyl-1-¬2'phenyl-2'oxoethyl-|piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy |
| 05/21/2002 | CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same |
| 05/16/2002 | WO2002038807A1 Method for screening agents capable of treating obesity |
| 05/16/2002 | WO2002038797A2 Modulators of bruton's tyrosine kinase, their identification and use |
| 05/16/2002 | WO2002038775A2 METHODS FOR PRODUCING AND PURIFYING RECOMBINANT α-L-IDURONIDASE |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038730A2 Novel human potassium channel beta subunit |
| 05/16/2002 | WO2002038646A2 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters |
| 05/16/2002 | WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
| 05/16/2002 | WO2002038570A1 Novel compounds |
| 05/16/2002 | WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors |
| 05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 05/16/2002 | WO2002038553A2 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists |
| 05/16/2002 | WO2002038551A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 05/16/2002 | WO2002038548A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 05/16/2002 | WO2002038547A1 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 05/16/2002 | WO2002038544A2 3-substituted oxindole beta 3 agonists |
| 05/16/2002 | WO2002038543A2 3-substituted oxindole beta 3 agonists |
| 05/16/2002 | WO2002038541A1 Cyanopyrrolidine derivatives |
| 05/16/2002 | WO2002038534A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 05/16/2002 | WO2002038181A2 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
| 05/16/2002 | WO2002038179A1 Preventives or remedies for endoplasmic reticulum stress-associated diseases |
| 05/16/2002 | WO2002038176A2 Immunogenic compositions comprising liver stage malarial antigens |
| 05/16/2002 | WO2002038171A2 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/16/2002 | WO2002038169A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | WO2002038160A1 Method for the treatment of inflammation |
| 05/16/2002 | WO2002038158A1 Improved treatment |
| 05/16/2002 | WO2002038151A1 Lipid peroxide-lowering compositions |
| 05/16/2002 | WO2002038140A2 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | WO2002038106A2 Calcilytic compounds |
| 05/16/2002 | WO2002038035A2 Methods for inhibiting pain |
| 05/16/2002 | WO2002030891A8 Aliphatic nitrogenous five-membered ring compounds |
| 05/16/2002 | WO2002030890A8 Nitrogenous five-membered ring compounds |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002020488A3 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 05/16/2002 | WO2002020026A3 Treatment of drug resistant organisms with nitric oxide |
| 05/16/2002 | WO2002020003A3 Use of carp inhibitors for the treatment of heart diseases |
| 05/16/2002 | WO2002018448A3 Percarboxylated polysaccharides, and a process for their preparation |
| 05/16/2002 | WO2002010158A3 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 05/16/2002 | WO2002003971A3 Pharmaceutical composition and method for the treatment of retroviral infections |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2002002090A3 Inhibitors of copper-containing amine oxidases |
| 05/16/2002 | WO2002000593A3 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001098290A3 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/16/2002 | WO2001097790A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 05/16/2002 | WO2001097789A3 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors |
| 05/16/2002 | WO2001096295A3 2-cyanopyrrolidine derivatives and their use as medicaments |
| 05/16/2002 | WO2001089514A3 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent |
| 05/16/2002 | WO2001087308B1 Treatment of fibromyalgia and chronic fatigue syndrome |
| 05/16/2002 | WO2001087287A3 Use of pyrazole derivatives for treating infertility |
| 05/16/2002 | WO2001087038A3 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001083478A3 Hydantoin-containing glucokinase activators |
| 05/16/2002 | WO2001083465A3 Alkynyl phenyl heteroaromatic glucokinase activators |
| 05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 05/16/2002 | WO2001079198A9 Pyrazoles for inhibiting protein kinase |
| 05/16/2002 | WO2001076638A3 Compositions for drug delivery |
| 05/16/2002 | WO2001070953A3 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 05/16/2002 | WO2001070662A3 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001066100A3 Pharmaceutical composition |
| 05/16/2002 | WO2001062668A3 Sulfur containing compounds |
| 05/16/2002 | WO2001047928A3 Imidazo 1,3,5 triazinones and the use thereof |
| 05/16/2002 | WO2001045664A3 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 05/16/2002 | WO2001045663A3 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |